In this study, we investigated the quantitative expression of cell surface markers in FLT3‐ITD AML from our local patient population, and evaluated the impact of both DNA and mRNA FLT3‐ITD/FLT3‐WT ratios on antigen expression levels. The gene discussed is FLT3; the disease is acute myeloid leukemia.